COSCIENS Biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.01	7.31	16.39	6.68	50.61	65.3
Cash & Short-Term Investments	5.01	7.31	16.39	6.68	50.61	65.3
Cash Growth	-63.62%	-55.43%	145.48%	-86.80%	-22.50%	169.04%
Accounts Receivable	1.99	1.08	1.88	0.13	0.4	0.88
Other Receivables	-	0.18	0.59	0.16	1.76	2.8
Receivables	1.99	1.26	2.47	0.29	2.16	3.68
Inventory	1.1	1.31	2.69	4.01	0.23	0.07
Prepaid Expenses	1.19	1.4	1.7	0.08	0.43	0.42
Other Current Assets	0.11	0.22	0.73	0.21	2.06	1.35
Total Current Assets	9.39	11.5	23.98	11.27	55.49	70.82
Property, Plant & Equipment	9.24	9.81	10.97	11.65	0.22	0.19
Goodwill	-	-	-	-	-	8.13
Other Intangible Assets	0	-	-	0.01	-	0.63
Long-Term Deferred Tax Assets	-	-	-	0.08	-	-
Other Long-Term Assets	0.2	0.13	0.12	0.75	0.32	0.34
Total Assets	18.84	21.43	35.07	23.75	56.03	80.1
Accounts Payable	0.59	0.75	2.41	0.28	2.04	0.93
Accrued Expenses	0.33	1.14	2.37	0.73	1.79	1.74
Current Portion of Leases	0.19	0.22	0.27	0.3	0.11	0.13
Current Income Taxes Payable	0	0.12	0.11	-	0.11	0.12
Current Unearned Revenue	-	-	0.12	-	2.95	4.82
Other Current Liabilities	0.57	1.39	1.95	-	0.05	0.03
Total Current Liabilities	1.69	3.61	7.22	1.31	7.04	7.77
Long-Term Leases	1.84	1.93	2.04	1.4	0.07	0.03
Long-Term Unearned Revenue	-	1.06	0.91	-	1.79	1.59
Pension & Post-Retirement Benefits	-	10.98	11.73	-	11.16	17.49
Other Long-Term Liabilities	-	-	-	-	0.19	0.24
Total Liabilities	3.52	17.59	21.91	2.71	20.25	27.12
Common Stock	22.63	22.62	22.49	13.52	293.41	293.41
Additional Paid-In Capital	-	-	-	-	90.33	-
Retained Earnings	-9.75	-20.51	-12.11	4.36	-352.08	-334.62
Comprehensive Income & Other	2.45	1.73	2.79	3.16	4.12	94.2
Shareholders' Equity	15.32	3.84	13.16	21.04	35.78	52.99
Total Liabilities & Equity	18.84	21.43	35.07	23.75	56.03	80.1
Total Debt	2.02	2.15	2.31	1.7	0.18	0.16
Net Cash (Debt)	2.98	5.16	14.08	4.98	50.43	65.14
Net Cash Growth	-74.14%	-63.37%	182.79%	-90.13%	-22.58%	170.43%
Net Cash Per Share	0.94	1.63	5.46	2.70	27.19	56.68
Filing Date Shares Outstanding	3.18	3.18	3.15	1.21	1.21	1.21
Total Common Shares Outstanding	3.18	3.18	3.14	1.21	1.21	1.21
Working Capital	7.71	7.89	16.76	9.96	48.44	63.05
Book Value Per Share	4.81	1.21	4.19	17.33	29.47	43.65
Tangible Book Value	15.32	3.84	13.16	21.03	35.78	44.23
Tangible Book Value Per Share	4.81	1.21	4.19	17.32	29.47	36.44
Machinery	10.18	10.74	10.9	11.98	0.45	0.47
Leasehold Improvements	5.85	5.95	5.64	6.68	-	-